FDA Update on Cyclospora Research, Prevention and Response

The FDA has updated its Cyclospora Prevention, Response and Research Action Plan. The action plan, which was developed in 2021 by the agency’s Cyclospora Task Force, details the FDA’s strategy for reducing the public health burden of foodborne cyclosporiasis in the U.S. and  defines the agency’s priorities for Cyclospora food safety research.

The updated action plan includes refined strategies, a report on accomplishments and three new actions that have been identified by the task force: advancing root cause analyses procedures, building a repository of Cyclospora oocysts that can be used for research and advancing the methods to conduct such research.

This year’s accomplishments cited by the FDA include:

 

Related Articles

About The Author

Exit mobile version